Metabolic profiles of regulatory T cells in the tumour microenvironment Disha RaoFabienne VerburgChristian U. Blank Review 12 February 2021 Pages: 2417 - 2427
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy Sabina SangalettiRoberto FerraraMario Paolo Colombo Review 02 April 2021 Pages: 2429 - 2438
Bruton’s tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment Logan GoodBrooke BennerWilliam E. Carson Review Open access 05 April 2021 Pages: 2439 - 2451
Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma Jianhan HuangMeijun ZhengLiangxue Zhou Original Article 04 February 2021 Pages: 2453 - 2465
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity Min YangEsther GiehlZong Sheng Guo Original Article Open access 04 February 2021 Pages: 2467 - 2481
Platelet-expressed immune checkpoint regulator GITRL in breast cancer Yanjun ZhouJonas S. HeitmannClemens Hinterleitner Original Article Open access 04 February 2021 Pages: 2483 - 2496
Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma Karam KhaddourSangeeta KhannaGeorge Ansstas Original Article Open access 05 February 2021 Pages: 2497 - 2502
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models Shunsuke GotoYukimi SakodaKoji Tamada Original Article 08 February 2021 Pages: 2503 - 2515
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China Xiangyu ZhangLiang ZengNong Yang Original Article 10 February 2021 Pages: 2517 - 2528
The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells Masanobu ShigaJun MiyazakiIkuya Yano Original Article 11 February 2021 Pages: 2529 - 2543
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC Vladimír KouckýKamila HladíkováAnna Fialová Original Article 11 February 2021 Pages: 2545 - 2557
Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors Li ZhongQing WuXianhe Xie Original Article 12 February 2021 Pages: 2559 - 2576
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung Torsten GoldmannSebastian MarwitzCarina Strell Original Article Open access 12 February 2021 Pages: 2577 - 2587
Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas Pei YangKuanyu WangXia Shan Original Article 12 February 2021 Pages: 2589 - 2600
Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling Shasha LiuChaoqi ZhangYi Zhang Original Article Open access 12 February 2021 Pages: 2601 - 2616
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial Kjetil BoyeAlessandra LonghiEmanuela Palmerini Original Article Open access 12 February 2021 Pages: 2617 - 2624
Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer Reem SalehVarun Sasidharan NairRanad Shaheen Original Article 13 February 2021 Pages: 2625 - 2638
Correction to: Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer Reem SalehVarun Sasidharan NairRanad Shaheen Correction 12 March 2021 Pages: 2639 - 2640
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration Keiichiro MoriIrene ReschShahrokh F. Shariat Original Article Open access 16 February 2021 Pages: 2641 - 2650
Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas Antonious HazimNeil MajithiaAaron S. Mansfield Original Article 18 February 2021 Pages: 2651 - 2656
Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy Junyu ChenWenlong ZhongTianxin Lin Original Article 19 February 2021 Pages: 2657 - 2668
Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers Chuanhua ZhaoLihong WuJianming Xu Original Article 23 February 2021 Pages: 2669 - 2679
Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer Łukasz ZadkaMariusz ChabowskiPiotr Dzięgiel Original Article Open access 24 February 2021 Pages: 2681 - 2700
Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15 Shannon L. McArdelAnne-Sophie DugastSivan Elloul Original Article Open access 09 July 2021 Pages: 2701 - 2719
Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus Aron Carlos de Melo CotrimEduardo Luzia FrançaInês Aparecida Tozetti Research Report 02 April 2021 Pages: 2721 - 2726
First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity Peter RufHartwig W. BauerHorst Lindhofer Research Report Open access 10 April 2021 Pages: 2727 - 2735